{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:41:51Z","timestamp":1787870511379,"version":"build-2784847793"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":158,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Abiogen Pharma S.p.a and Associazione Italiana per la Ricerca sul Cancro","award":["IG30806"],"award-info":[{"award-number":["IG30806"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Vitamin D (VitD) signaling is implicated in cancer and immune regulation, but its role in glioblastoma (GBM) remains unclear. We investigated the prognostic impact of VitD levels, VDR expression, and polymorphisms in VitD-related genes in GBM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ninety GBM tumors (62 primary, 28 recurrent) were analyzed. Circulating 25-hydroxyvitamin D (25(OH)D) was measured in 54 cases; tumor VDR mRNA\/protein, calcitriol, and CYP24A1\/CYP27B1\/CYP27A1 proteins were assessed. Whole-exome sequencing identified SNPs in the VitD-pathway genes. Associations with overall (OS) and progression-free survival (PFS) were evaluated by Kaplan-Meier and Cox models. Transcriptomic profiles were explored by GSEA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Severe 25(OH)D deficiency (&amp;lt;10 ng\/mL) was frequent (13 primary, 38.2%; 11, recurrent 55.0%). Patients with &amp;lt;10 ng\/mL had significantly shorter OS than patients with higher levels (9 vs. 18 months; HR\u2009=\u20092.55, 95% CI 1.03-6.39, P\u2009=\u2009.045). High VDR protein was associated with longer PFS (13.1 vs. 4.7 months, P\u2009=\u2009.027). CYP27B1 variants rs4646536 and rs703842 were associated with shorter OS (\u223c9-11 vs. \u223c23-24 months; P\u2009&amp;lt;\u2009.05), although statistical significance was attenuated after correction for multiple testing. Transcriptomic analysis showed that CYP27B1 wild-type tumors were enriched for immune-related programs (B\/T\/NK-cell cytotoxicity, interferon response, antigen presentation; FDR &amp;lt; 0.25), while SNP tumors displayed minimal activation, consistent with poorer outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Severe VitD deficiency (&amp;lt;10 ng\/mL) and CYP27B1 variants (rs4646536, rs703842) were associated with poorer prognosis in GBM. These exploratory findings suggest that systemic VitD status and genetic variation in its metabolism may influence GBM progression and tumor-immune interactions, warranting validation in independent cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/noajnl\/vdag158","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T11:42:56Z","timestamp":1780746176000},"source":"Crossref","is-referenced-by-count":1,"title":["Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastoma"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8796-4037","authenticated-orcid":false,"given":"Mariangela","family":"Morelli","sequence":"first","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Lorenzo","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marchetto","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Menicagli","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Franceschi","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Giacomarra","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Gambacciani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Azienda Ospedaliera Toscana Nord-ovest , Livorno,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pieri","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Azienda Ospedaliera Toscana Nord-ovest , Livorno,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pasqualetti","sequence":"additional","affiliation":[{"name":"Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche (DiSCOG), Universit\u00e0 di Padova , Padova,","place":["Italy"]},{"name":"Radiotherapy Unit, Veneto Institute of Oncology - IRCCS , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Aretini","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin Gerard","family":"Egan","sequence":"additional","affiliation":[{"name":"CE Medical Writing SRLS , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Trasciatti","sequence":"additional","affiliation":[{"name":"Galileo Research Srl , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santina","family":"Battaglia","sequence":"additional","affiliation":[{"name":"Medical Research, Abiogen Pharma , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Solfanelli","sequence":"additional","affiliation":[{"name":"Medical Research, Abiogen Pharma , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Nannipieri","sequence":"additional","affiliation":[{"name":"Medical Research, Abiogen Pharma , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio Santo","family":"Santonocito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Azienda Ospedaliera Toscana Nord-ovest , Livorno,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Luisa","family":"Di Stefano","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Azienda Ospedaliera Toscana Nord-ovest , Livorno,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lessi","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Maria","family":"Mazzanti","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza , Pisa,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2026062519564881500_vdag158-B1","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s00701-022-05301-y","article-title":"The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know\u2014a minireview","volume":"164","author":"Torp","year":"2022","journal-title":"Acta Neurochir (Wien)"},{"key":"2026062519564881500_vdag158-B2","first-page":"143","volume-title":"Epidemiology and Outcome of Glioblastoma, Glioblastoma [Internet].","author":"Tamimi","year":"2017:"},{"key":"2026062519564881500_vdag158-B3","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"key":"2026062519564881500_vdag158-B4","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"2026062519564881500_vdag158-B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12883-022-03047-9","article-title":"Clinical characteristics and prognosis of glioblastoma patients with infratentorial recurrence","volume":"23","author":"Kawauchi","year":"2023","journal-title":"BMC Neurol"},{"key":"2026062519564881500_vdag158-B6","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.3390\/cancers15174279","article-title":"Recurrent glioblastoma: a review of the treatment options","volume":"15","author":"Vaz-Salgado","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2026062519564881500_vdag158-B7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects","volume":"96","author":"Christakos","year":"2016","journal-title":"Physiol Rev"},{"key":"2026062519564881500_vdag158-B8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jsbmb.2014.11.002","article-title":"Membrane-mediated actions of 1,25-dihydroxy vitamin D3: a review of the roles of phospholipase A2 activating protein and Ca2+\/calmodulin-dependent protein kinase II","volume":"147","author":"Doroudi","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026062519564881500_vdag158-B9","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/exd.14147","article-title":"Vitamin D receptor(s): in the nucleus but also at membranes?","volume":"29","author":"Zmijewski","year":"2020","journal-title":"Exp Dermatol"},{"key":"2026062519564881500_vdag158-B10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41374-021-00673-8","article-title":"Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications","volume":"102","author":"Lo","year":"2022","journal-title":"Lab Invest"},{"key":"2026062519564881500_vdag158-B11","doi-asserted-by":"publisher","first-page":"937476","DOI":"10.3389\/fimmu.2022.937476","article-title":"Vitamin D metabolism pathway polymorphisms are associated with efficacy and safety in patients under anti-PD-1 inhibitor therapy","volume":"13","author":"Luo","year":"2022","journal-title":"Front Immunol"},{"key":"2026062519564881500_vdag158-B12","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/cancers16183211","article-title":"Vitamin D in cancer prevention and treatment: a review of epidemiological, preclinical, and cellular studies","volume":"16","author":"Dallavalasa","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026062519564881500_vdag158-B13","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.3390\/molecules25143219","article-title":"Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications","volume":"25","author":"El-Sharkawy","year":"2020","journal-title":"Molecules"},{"key":"2026062519564881500_vdag158-B14","author":"Vitamin D and Cancer\u2014NCI;","year":"2023"},{"key":"2026062519564881500_vdag158-B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12061798","article-title":"Vitamin D-induced molecular mechanisms to potentiate cancer therapy and to reverse drug-resistance in cancer cells","volume":"12","author":"Negri","year":"2020","journal-title":"Nutrients"},{"key":"2026062519564881500_vdag158-B16","volume-title":"StatPearls [Internet].","author":"Kaur","year":"2025"},{"key":"2026062519564881500_vdag158-B17","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s41430-020-0558-y","article-title":"Vitamin D deficiency 2.0: an update on the current status worldwide","volume":"74","author":"Amrein","year":"2020","journal-title":"Eur J Clin Nutr"},{"key":"2026062519564881500_vdag158-B18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/nbu.12108","article-title":"Vitamin D: an overview of vitamin D status and intake in Europe","volume":"39","author":"Spiro","year":"2014","journal-title":"Nutr Bull"},{"key":"2026062519564881500_vdag158-B19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.annepidem.2007.12.001","article-title":"Vitamin D status: measurement, interpretation and clinical application","volume":"19","author":"Holick","year":"2009","journal-title":"Ann Epidemiol"},{"key":"2026062519564881500_vdag158-B20","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.3390\/cancers13143577","article-title":"Calcitriol promotes differentiation of glioma stem-like cells and increases their susceptibility to temozolomide","volume":"13","author":"Gerstmeier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026062519564881500_vdag158-B21","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.3390\/cancers15215249","article-title":"Molecular determinants of calcitriol signaling and sensitivity in glioma stem-like cells","volume":"15","author":"Rehbein","year":"2023","journal-title":"Cancers (Basel)"},{"issue":":e94542.","key":"2026062519564881500_vdag158-B22","doi-asserted-by":"publisher","DOI":"10.5812\/ijcm.94542","article-title":"In vitro and in vivo antitumor activity of vitamin D3 in malignant gliomas: a systematic review","volume":"13","author":"Hajimohammadebrahim-Ketabforoush","year":"2020","journal-title":"Int J Cancer Manag"},{"key":"2026062519564881500_vdag158-B23","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1016\/j.ijrobp.2017.06.468","article-title":"Vitamin D levels in blood and survival in glioblastoma","volume":"99","author":"Franc\u00e9s","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026062519564881500_vdag158-B24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.clnesp.2023.04.009","article-title":"Optimal vitamin D status at admission appears to improve survival after craniotomy in patients with brain malignancies","volume":"55","author":"Shahmohammadi","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"2026062519564881500_vdag158-B25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/nu15061525","article-title":"Polymorphisms in VDR, CYP27B1, CYP2R1, GC and CYP24A1 genes as biomarkers of survival in non-small cell lung cancer: a systematic review","volume":"15","author":"Pineda-Lancheros","year":"2023","journal-title":"Nutrients"},{"key":"2026062519564881500_vdag158-B26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/diseases13070219","article-title":"The association of VDR, CYP2R1, and GC gene polymorphisms, dietary intake, and BMI in regulating vitamin D status","volume":"13","author":"Stroia","year":"2025","journal-title":"Diseases"},{"key":"2026062519564881500_vdag158-B27","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/biom15050699","article-title":"Genetic polymorphism of CYP2R1, CYP27A1, CYP27B1, and vitamin D metabolites plasma levels in patients with cardiovascular disease: a pilot study","volume":"15","author":"Abouzid","year":"2025","journal-title":"Biomolecules"},{"key":"2026062519564881500_vdag158-B28","doi-asserted-by":"publisher","first-page":"E2133","DOI":"10.1210\/jc.2014-1389","article-title":"Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial","volume":"99","author":"Barry","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026062519564881500_vdag158-B29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/carcin\/bgp103","article-title":"Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk","volume":"30","author":"Raimondi","year":"2009","journal-title":"Carcinogenesis"},{"key":"2026062519564881500_vdag158-B30","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s11604-025-01821-6","article-title":"RANO 2.0: critical updates and practical considerations for radiological assessment in neuro-oncology","volume":"43","author":"Sakata","year":"2025","journal-title":"Jpn J Radiol"},{"key":"2026062519564881500_vdag158-B31","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026062519564881500_vdag158-B32","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026062519564881500_vdag158-B33","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/jim-2016-000206","article-title":"P values: from suggestion to superstition","volume":"64","author":"Concato","year":"2016","journal-title":"J Investig Med"},{"key":"2026062519564881500_vdag158-B34","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"2026062519564881500_vdag158-B35","doi-asserted-by":"publisher","first-page":"1070808","DOI":"10.3389\/fnut.2023.1070808","article-title":"Global and regional prevalence of vitamin D deficiency in population-based studies from 2000 to 2022: a pooled analysis of 7.9 million participants","volume":"10","author":"Cui","year":"2023","journal-title":"Front Nutr"},{"key":"2026062519564881500_vdag158-B36","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1590\/1806-9282.20220516","article-title":"Association of 25-hydroxyvitamin D with hematological profile and anthropometry in patients with glioma","volume":"68","author":"Shahid","year":"2022","journal-title":"Rev Assoc Med Bras"},{"key":"2026062519564881500_vdag158-B37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/BF01420072","article-title":"Effects of vitamin D and retinoic acid on human glioblastoma cell lines","volume":"133","author":"Magrassi","year":"1995","journal-title":"Acta Neurochir (Wien)"},{"key":"2026062519564881500_vdag158-B38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11060-014-1416-3","article-title":"Vitamin D receptor expression is associated with improved overall survival in human glioblastoma multiforme","volume":"118","author":"Salom\u00f3n","year":"2014","journal-title":"J Neurooncol"},{"key":"2026062519564881500_vdag158-B39","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1158\/1078-0432.CCR-04-1968","article-title":"Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol","volume":"11","author":"Diesel","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2026062519564881500_vdag158-B40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Greenbaum","year":"2003","journal-title":"Genome Biol"},{"key":"2026062519564881500_vdag158-B41","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.22716","article-title":"Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics","volume":"109","author":"Seubwai","year":"2007","journal-title":"Cancer"},{"key":"2026062519564881500_vdag158-B42","first-page":"1591","article-title":"Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer","volume":"4","author":"Evans","year":"1998","journal-title":"Clin Cancer Res"},{"key":"2026062519564881500_vdag158-B43","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.lungcan.2012.04.010","article-title":"Characterization of vitamin D receptor (VDR) in lung adenocarcinoma","volume":"77","author":"Kim","year":"2012","journal-title":"Lung Cancer"},{"key":"2026062519564881500_vdag158-B44","first-page":"239","article-title":"Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis","volume":"51","author":"Berger","year":"1991","journal-title":"Cancer Res"},{"key":"2026062519564881500_vdag158-B45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2010.06.008","article-title":"Analysis of vitamin D receptor expression and clinical correlations in patients with ovarian cancer","volume":"119","author":"Silvagno","year":"2010","journal-title":"Gynecol Oncol"},{"key":"2026062519564881500_vdag158-B46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11523-013-0255-z","article-title":"Is 1,25-dihydroxyvitamin D3 receptor expression a potential Achilles\u2019 heel of CD44+ oral squamous cell carcinoma cells?","volume":"8","author":"Grimm","year":"2013","journal-title":"Targ Oncol"},{"key":"2026062519564881500_vdag158-B47","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10552-012-0018-7","article-title":"An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome","volume":"23","author":"Anic","year":"2012","journal-title":"Cancer Causes Control"},{"key":"2026062519564881500_vdag158-B48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2265.2011.04261.x","article-title":"An update on vitamin D and human immunity","volume":"76","author":"Hewison","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026062519564881500_vdag158-B49","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ecl.2017.07.010","article-title":"Regulation of immune function by vitamin D and its use in diseases of immunity","volume":"46","author":"Vanherwegen","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2026062519564881500_vdag158-B50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-immunol-030409-101216","article-title":"Early events in B cell activation","volume":"28","author":"Harwood","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"2026062519564881500_vdag158-B51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"2026062519564881500_vdag158-B52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2026062519564881500_vdag158-B53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2026062519564881500_vdag158-B54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2026062519564881500_vdag158-B55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"2026062519564881500_vdag158-B56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ccell.2022.12.007","article-title":"MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors","volume":"41","author":"Kilian","year":"2023","journal-title":"Cancer Cell"},{"key":"2026062519564881500_vdag158-B57","doi-asserted-by":"publisher","first-page":"1375858","DOI":"10.1155\/2016\/1375858","article-title":"Crosstalk between vitamin D metabolism, VDR signalling, and innate immunity","volume":"2016","author":"Lin","year":"2016","journal-title":"Biomed Res Int"},{"key":"2026062519564881500_vdag158-B58","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/nu7095383","article-title":"Regulation of dendritic cell function by vitamin D","volume":"7","author":"Barragan","year":"2015","journal-title":"Nutrients"},{"key":"2026062519564881500_vdag158-B59","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3389\/fimmu.2019.02587","article-title":"Innate immune response regulation by the human RNASET2 tumor suppressor gene","volume":"10","author":"Acquati","year":"2019","journal-title":"Front Immunol"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdag158\/68490696\/vdag158.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag158\/68490696\/vdag158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag158\/68490696\/vdag158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:56:55Z","timestamp":1782431815000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdag158\/8703987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdag158","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"vdag158"}}